Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA

[1]  M. Wilkinson.  Genetic paradox explained by nonsense , 2019, Nature.

[2]  Diana C. Rostirolla,et al.  Nuclear RXRα and RXRβ receptors exert distinct and opposite effects on RA-mediated neuroblastoma differentiation. , 2019, Biochimica et biophysica acta. Molecular cell research.

[3]  G. Aguiari,et al.  MicroRNA501‐5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells , 2018, Journal of cellular physiology.

[4]  N. Bianchi,et al.  Spotlight on the transglutaminase 2 gene: a focus on genomic and transcriptional aspects. , 2018, The Biochemical journal.

[5]  Cong Pian,et al.  Identification of cancer-related miRNA-lncRNA biomarkers using a basic miRNA-lncRNA network , 2018, PloS one.

[6]  D. Normolle,et al.  A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia , 2018, Leukemia & lymphoma.

[7]  N. Zheng,et al.  Zinc knuckle of TAF1 is a DNA binding module critical for TFIID promoter occupancy , 2018, Scientific Reports.

[8]  S. Volinia,et al.  A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants , 2018, Amino Acids.

[9]  M. Piacentini,et al.  Transglutaminase 2, a double face enzyme , 2017, Amino Acids.

[10]  F. Markowetz,et al.  BaalChIP: Bayesian analysis of allele-specific transcription factor binding in cancer genomes , 2016, Genome Biology.

[11]  David J Weber,et al.  Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival , 2016, Oncogene.

[12]  A. Feeney,et al.  YY1 plays an essential role at all stages of B-cell differentiation , 2016, Proceedings of the National Academy of Sciences.

[13]  A. Yen,et al.  Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expression , 2015, FEBS open bio.

[14]  K. Baker,et al.  Nonsense‐mediated RNA decay – a switch and dial for regulating gene expression , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.

[15]  K. Yanai,et al.  Identification and Characterization of Human Genomic Binding Sites for Retinoic Acid Receptor/Retinoid X Receptor Heterodimers , 2015 .

[16]  Yuquan Wei,et al.  Essential role of GATA3 in regulation of differentiation and cell proliferation in SK-N-SH neuroblastoma cells , 2014, Molecular medicine reports.

[17]  R. Evans,et al.  The active enhancer network operated by liganded RXR supports angiogenic activity in macrophages , 2014, Genes & development.

[18]  E. Bonmassar,et al.  Molecular mechanisms involved in HIV-1-Tat mediated inhibition of telomerase activity in human CD4(+) T lymphocytes. , 2013, Molecular immunology.

[19]  Juan M. Vaquerizas,et al.  DNA-Binding Specificities of Human Transcription Factors , 2013, Cell.

[20]  Fiona G. G. Nielsen,et al.  Chromatin accessibility, p300, and histone acetylation define PML-RARα and AML1-ETO binding sites in acute myeloid leukemia. , 2012, Blood.

[21]  A. Pession,et al.  Retinoids in Pediatric Onco-Hematology: the Model of Acute Promyelocytic Leukemia and Neuroblastoma , 2012, Advances in Therapy.

[22]  Soo-Youl Kim,et al.  Transglutaminase-2 Is Involved in All-Trans Retinoic Acid-Induced Invasion and Matrix Metalloproteinases Expression of SH-SY5Y Neuroblastoma Cells via NF-κB Pathway , 2012, Biomolecules & therapeutics.

[23]  L. Fésüs,et al.  Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+‐dependent action of a multifunctional protein , 2011, The FEBS journal.

[24]  R. Young,et al.  Histone H3K27ac separates active from poised enhancers and predicts developmental state , 2010, Proceedings of the National Academy of Sciences.

[25]  H. Gronemeyer,et al.  Discovery of novel transcriptional and epigenetic targets in APL by global ChIP analyses: Emerging opportunity and challenge. , 2010, Cancer cell.

[26]  R. Pfundt,et al.  Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. , 2009, Blood.

[27]  M. Haber,et al.  Opposing Effects of Two Tissue Transglutaminase Protein Isoforms in Neuroblastoma Cell Differentiation* , 2009, The Journal of Biological Chemistry.

[28]  D. Komura,et al.  A wave of nascent transcription on activated human genes , 2009, Proceedings of the National Academy of Sciences.

[29]  J. Zlatanova,et al.  CTCF and its protein partners: divide and rule? , 2009, Journal of Cell Science.

[30]  P. Casaccia‐Bonnefil,et al.  The Yin and Yang of YY1 in the nervous system , 2008, Journal of neurochemistry.

[31]  N. Tomilin,et al.  SINEs in mammalian genomes can serve as additional signals in formation of facultative heterochromatin , 2008, Cell and Tissue Biology.

[32]  P. Sharp,et al.  Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.

[33]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[34]  Stefan Rotter,et al.  Strong Interactions in Multimode Random Lasers , 2008, Science.

[35]  C. Bergamini.  Effects of ligands on the stability of tissue transglutaminase: studies in vitro suggest possible modulation by ligands of protein turn-over in vivo , 2007, Amino Acids.

[36]  L. Fésüs,et al.  Transglutaminase 2 in the balance of cell death and survival , 2005, FEBS letters.

[37]  H. Osaka,et al.  Retinoic Acid Induces Neuroblastoma Cell Death by Inhibiting Proteasomal Degradation of Retinoic Acid Receptor α , 2004, Cancer Research.

[38]  H. de Thé,et al.  PML–RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation , 2004, The Journal of experimental medicine.

[39]  Rita Casadio,et al.  Transglutaminases: nature's biological glues. , 2002, The Biochemical journal.

[40]  J. Jurka.  Repbase update: a database and an electronic journal of repetitive elements. , 2000, Trends in genetics : TIG.

[41]  J. Manley,et al.  Mechanism and regulation of mRNA polyadenylation. , 1997, Genes & development.

[42]  R. Gonzales,et al.  A third human tissue transglutaminase homologue as a result of alternative gene transcripts. , 1996, Biochimica et biophysica acta.

[43]  G. Avvisati,et al.  Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase. , 1996, Blood.

[44]  S. Collins,et al.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[45]  L. Maquat,et al.  Identifying Cellular Nonsense-Mediated mRNA Decay (NMD) Targets: Immunoprecipitation of Phosphorylated UPF1 Followed by RNA Sequencing (p-UPF1 RIP-Seq). , 2018, Methods in molecular biology.

[46]  Z. Szondy,et al.  FOR THE DEGREE OF DOCTOR OF PHILOSOPHY ( P H D ) TRANSCRIPTIONAL CONTROL OF TRANSGLUTAMINASE 2 EXPRESSION IN MOUSE APOPTOTIC THYMOCYTES , 2016 .

[47]  D. Langford,et al.  Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. , 2013, Methods in molecular biology.

[48]  Roger D Kornberg,et al.  RNA polymerase II transcription: structure and mechanism. , 2013, Biochimica et biophysica acta.

[49]  C. Greenberg,et al.  TGM2 and implications for human disease: role of alternative splicing. , 2013, Frontiers in bioscience.

[50]  D. C. Hughes,et al.  Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancer , 2011, Amino Acids.

[51]  Ton Feuth,et al.  Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes , 2005, Laboratory Investigation.